Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jan 08, 2022 3:29pm
329 Views
Post# 34296509

Did Rob Have an Inkling?

Did Rob Have an Inkling?Thank goodness Rob didn't wait around for REB and HC approval to carry out clinical trials in Canada. One has to wonder if he had some idea that HC bureaucracy would be so extremely slow that they applied for and received approval for the clinical trials in Brazil a week after their application in Canada (last March).

How slow? Health Canada authorized only 7 rapid antigen POC test devices in ALL of 2021. They didn't authorize any in July, August or September ...one in each of October, November and December. Before anyone thinks there were a great deal of submissions to go through ...there weren't.

It also puts into perspective the David and Goliath story and the challenges Rob has faced with timelines. Looking forward to an exciting week ahead.

Cheers!!!
<< Previous
Bullboard Posts
Next >>